We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Mitochondrial DNA Levels Tied to Outcome in Critically ill Patients

By HospiMedica staff writers
Posted on 02 Oct 2007
Increasing blood-cell levels of mitochondrial DNA (MtDNA) appear to be associated with short-term survival in critically ill patients, according to a new study.

Researchers at the University of British Columbia (Vancouver, Canada) prospectively studied mitochondrial DNA levels--and indication of mitochondrial function--in 28 hypotensive, mechanically ventilated, critically ill intensive care unit (ICU) patients.

The researchers found that at baseline, the ratio of mitochondrial to nuclear DNA was about 30% lower than that seen in 24 control subjects. More...
By day four, the change in this ratio in survivors (+29.5%) was significantly greater than that seen in non-survivors (-5.7%). The change also tended to be higher in survivors at the last measurement than in non-survivors (38.4% versus 7.1%). The researchers suggest that the results hint that some mitochondrial shutdown may take place in humans during shock, providing corroborative evidence to observations obtained from animal models. The study was published in the August 15, 2007, issue of Critical Care.

"Blood mitochondrial DNA levels appeared initially low, increased over time in patients who ultimately survived, and remained low in those who did not,” said lead investigator Dr. Helene C. F. Cote. "The findings are consistent with mitochondrial dysfunction playing a role in shock, and open new research avenues.”

Mitochondrial DNA is located in the mitochondria, parts of the cell that generate fuel in the form of adenosine triphosphate (ATP), which drives the varied machinery of the cell. Because mitochondrial DNA is inherited only from the mother, it provides an unaltered link to past generations, serving as a genetic research tool.


Related Links:
University of British Columbia

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.